Skip to content

The proportion and disease characteristics of PHACE syndrome in infants with facial segmental hemangioma in China: A multicenter, cross-sectional study

The proportion and disease characteristics of PHACE syndrome in infants with facial segmental hemangioma in China: A multicenter, cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087805
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PHACE Syndrome

Interventions

None:None

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 3 Years

Inclusion criteria

Inclusion criteria: 1. Children under 3 years old (including 3 years old), regardless of gender; 2. According to the medical history, clinical manifestations, and imaging (B-ultrasonography, CT or MRI), the diagnosis was confirmed as infant facial segmental hemangioma; 3. The guardian of the child understands the research content, signs the informed consent, and is willing to cooperate with the research

Exclusion criteria

Exclusion criteria: 1. The guardian of the child refused to accept diagnostic examinations related to PHACE syndrome (including physical examination, brain MRI, head and neck MRA, echocardiography and ophthalmic specialist examination); 2. The researchers believe that the children are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
The proportion of patients with PHACE syndrome in patients with facial segmental hemangioma;

Secondary

MeasureTime frame
Disease characteristics of PHACE syndrome in Chinese children;

Countries

China

Contacts

Public ContactXiaoxi Lin

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

linxiaoxi@126.com+86 137 0199 7136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026